Effectiveness of Health Literacy Program for Polypharmacy Patients (HLP-CKD)
HLP-CKD
Effectiveness of the Health Literacy Promotion Program to Prevent Chronic Kidney Disease of Patients Who Use Polypharmacy
2 other identifiers
interventional
104
1 country
1
Brief Summary
This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedStudy Start
First participant enrolled
June 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 15, 2026
June 4, 2026
May 1, 2026
3 months
May 27, 2026
June 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Health Literacy Levels
The total score of health literacy regarding chronic kidney disease (CKD) prevention, assessed using a validated Health Literacy Questionnaire. The tool evaluates 6 domains: access, understanding, communication, questioning, decision-making, and practice. Higher scores indicate a higher level of health literacy.
Baseline, 8 weeks (immediately after intervention), and 12 weeks (follow-up).
CKD Prevention Behaviors
The assessment of self-care behaviors to prevent chronic kidney disease, such as medication adherence, dietary control, and physical activity. Evaluated using the CKD Prevention Behavior Scale.
Baseline, 8 weeks, and 12 weeks.
Secondary Outcomes (3)
Estimated Glomerular Filtration Rate (eGFR)
Baseline and 12 weeks (follow-up)
Serum Creatinine
Baseline and 12 weeks (follow-up)
Urine Albumin-to-Creatinine Ratio (UACR)
Baseline and 12 weeks (follow-up).
Study Arms (2)
Experimental Group
EXPERIMENTALParticipants in this group will receive the 8-week Health Literacy Promotion Program (HLP-CKD), which includes educational sessions, skill-building for medication management, and follow-up support.
Control Group
ACTIVE COMPARATORParticipants in this group will receive routine nursing care and standard health education provided by the healthcare facility.
Interventions
An 8-week program consisting of educational sessions, skill-building for medication management, and follow-up support to prevent chronic kidney disease.
Eligibility Criteria
You may qualify if:
- Patients aged 55-74 years diagnosed with non-communicable diseases.
- Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
- Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
- Able to communicate, read, and write in Thai.
- Willing to participate in the 8-week program and follow-up assessments.
You may not qualify if:
- Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5.
- Having severe cognitive impairment or psychiatric disorders that prevent participation.
- Having severe complications or being in an unstable clinical condition.
- Planning to move out of the study area during the 12-week study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Promoting Hospital
Nakhon Pathom, Changwat Nakhon Pathom, 73000, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wanpen Waelveerakup, Dr.P.H.
Faculty of Nursing, Nakhon Pathom Rajabhat University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor, who is responsible for data collection and evaluation, is blinded to the group assignment to minimize assessment bias.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 27, 2026
First Posted
June 2, 2026
Study Start
June 15, 2026
Primary Completion (Estimated)
September 15, 2026
Study Completion (Estimated)
November 15, 2026
Last Updated
June 4, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect the privacy and confidentiality of the participants, in accordance with the informed consent and institutional ethical guidelines.